Urinalysis Market

The urinalysis market is expected to reach USD 7.16 billion by 2031 from USD 4.88 billion in 2026, at a CAGR of 8.0%.

The urinalysis market is growing primarily due to the rising prevalence of urinary tract infections (UTIs), diabetes, and kidney and liver diseases, as well as the expanding geriatric population and associated age-related conditions. The growing adoption of point-of-care (PoC) diagnostic testing is also supporting market expansion. Additionally, increasing awareness of preventive healthcare and rising healthcare expenditure, particularly in emerging economies, are encouraging investment in advanced urinalysis products and diagnostic infrastructure. However, the availability of refurbished urine analyzers may limit market growth to some extent.

To know about the assumptions considered for the study download the pdf brochure

In December 2023, Siemens Healthineers AG (Germany) launched the Atellica UAS 60 Analyzer, a compact instrument for automated urine sediment analysis. The launch aimed to expand Siemens Healthineers' urinalysis instrument portfolio and to support laboratories with a space-efficient, high-throughput solution for accurate sediment testing.

In January 2025, Cardinal Health Inc. (US) expanded its distribution network by opening a new distribution center in Fort Worth, Texas. The expansion aimed to strengthen support for its At-Home Solutions business and improve the efficiency and reach of its distribution operations across the region.

The key players in this market include Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Abbott (US), Bio-Rad Laboratories, Inc. (US), QuidelOrtho Corporation (Japan), and Waters Corporation (US). Market participants have pursued a range of strategies to strengthen their market position, including advanced product development, partnerships, expansions, and acquisitions. These organic and inorganic strategies have enabled market participants to expand their reach across geographies by offering advanced urinalysis tests.

Siemens Healthineers AG (Germany) emerged as the leading player in the urinalysis market in 2025. The company has a strong global presence, supported by its comprehensive portfolio of urinalysis products and solutions. Its market position is further strengthened by continuous investments in research and development, enabling the company to introduce innovative technologies and products. Siemens Healthineers also focuses on strategic initiatives, including partnerships, collaborations, and business expansions, to strengthen its product portfolio, expand market reach, and maintain its competitive position.

F. Hoffmann-La Roche Ltd. (Switzerland) held a significant share of the urinalysis market in 2025. The company maintains a strong position in biochemical urinalysis, supported by its broad portfolio of urine analyzers and test strips. Roche emphasizes product innovation and invests substantially in R&D to develop advanced diagnostic solutions and strengthen its market presence. Its extensive global sales and distribution network further supports the availability of its urinalysis products across multiple countries, contributing to its strong market position.

Market Ranking

Siemens Healthineers AG (Germany) has emerged as the leading player in the urinalysis market, supported by a comprehensive portfolio of urine analyzers, test strips, and automated urinalysis systems, along with a strong global presence. F. Hoffmann-La Roche Ltd. (Switzerland) is another significant participant, leveraging a broad portfolio of urine analyzers and test strips, automated diagnostic solutions, and a strong focus on innovation and product development. Cardinal Health (US) holds a prominent position in the urinalysis market through its extensive distribution network and broad presence across healthcare facilities and diagnostic settings, supporting the availability of urinalysis products on a large scale. Danaher Corporation (US), through its Beckman Coulter diagnostics business, maintains a strong position with advanced automated urinalysis solutions and a continued focus on laboratory efficiency and throughput. Abbott (US) also plays an important role in the urinalysis market, supported by its point-of-care diagnostic portfolio and a continued focus on developing rapid, reliable testing solutions for decentralized and outpatient settings.

Related Reports:

Urinalysis Market by Product (Consumables [Disposable, Reagents],Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]